{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,30]],"date-time":"2026-10-30T07:28:49Z","timestamp":1793345329614,"version":"4.5.0"},"reference-count":51,"publisher":"The Pediatric Pharmacy Association","issue":"5","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2019]]},"abstract":"<jats:p>Calcium channel blockers (CCBs) are commonly prescribed cardiovascular medications used in several disease states including hypertension, coronary artery disease, and atrial fibrillation. Inadvertent exposure or intentional overdose of CCBs may result in hypotension, bradycardia, dysrhythmias, conduction disturbances, and hyperglycemia. In the most severe cases, CCB toxicity can lead to rapid cardiovascular collapse. Given the risk of significant morbidity and mortality associated with CCB toxicity, it is important that health care professionals are able to recognize and treat patients who present with a potentially toxic ingestion. Due to the paucity of literature in managing pediatric patients with severe CCB toxicity, treatment strategies for pediatric patients are mostly limited to case reports and extrapolation from expert consensus recommendations for adults. All pediatric patients with a potentially toxic CCB ingestion should be evaluated in the emergency department. Activated charcoal may be considered for asymptomatic patients presenting within an hour of ingestion. Symptomatic patients should be placed under cardiac monitoring and treatments to stabilize the patient's hemodynamics should not be delayed. Traditional first-line IV therapies include small boluses of fluids, calcium, and vasopressors. High-dose insulin has been proposed to independently increase inotropy and improve CCB-induced hypoinsulinemia and insulin resistance that results from CCB inhibition of insulin release from pancreatic \u03b2-islet cells. High-dose insulin is recommended as first-line therapy for adults and shows promising efficacy and safety in several pediatric case reports. Intravenous lipid emulsion may be considered in patients who are refractory to first-line therapies, although the data for pediatric patients are extremely limited.<\/jats:p>","DOI":"10.5863\/1551-6776-24.5.378","type":"journal-article","created":{"date-parts":[[2019,10,7]],"date-time":"2019-10-07T20:38:50Z","timestamp":1570480730000},"page":"378-389","source":"Crossref","is-referenced-by-count":5,"title":["Management of Calcium Channel Blocker Toxicity in the Pediatric Patient"],"prefix":"10.5863","volume":"24","author":[{"given":"Jenna W.","family":"Bartlett","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pamela L.","family":"Walker","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"3883","reference":[{"issue":"10","key":"i1551-6776-24-5-378-b1","series-title":"Clin Toxicol (Phila)","first-page":"1072","article-title":"2016 Annual Report of the American Association of Poison Control Centers' National Poison Data System (NPDS): 34th Annual Report","volume":"55","year":"2017","unstructured":"Gummin\n              DD\n            , MowryJB, SpykerDA, \n          et al. 2016 Annual Report of the American Association of Poison Control Centers' National Poison Data System (NPDS): 34th Annual Report. Clin Toxicol (Phila). 2017;55(10):1072\u20131252."},{"issue":"2","key":"i1551-6776-24-5-378-b2","series-title":"J Emerg Med","first-page":"145","article-title":"Are one or two dangerous? Calcium channel blocker exposure in toddlers","volume":"33","year":"2007","unstructured":"Ranniger\n              C\n            , RocheC.\n          Are one or two dangerous? Calcium channel blocker exposure in toddlers. J Emerg Med. 2007;33(2):145\u2013154."},{"issue":"4","key":"i1551-6776-24-5-378-b3","series-title":"J Emerg Med","first-page":"359","article-title":"Fatal nifedipine ingestions in children","volume":"19","year":"2000","unstructured":"Lee\n              DC\n            , GreeneT, DoughertyT, PearigenP.\n          Fatal nifedipine ingestions in children. J Emerg Med. 2000;19(4):359\u2013361."},{"issue":"2","key":"i1551-6776-24-5-378-b4","series-title":"Drug Saf","first-page":"65","article-title":"Management of calcium channel antagonist overdose","volume":"26","year":"2003","unstructured":"Salhanick\n              SD\n            , ShannonMW.\n          Management of calcium channel antagonist overdose. Drug Saf. 2003;26(2):65\u201379."},{"issue":"6","key":"i1551-6776-24-5-378-b5","series-title":"Indian J Pediatr","first-page":"513","article-title":"Near fatal case of amlodipine poisoning in an infant","volume":"80","year":"2013","unstructured":"Nimbalkar\n              SM\n            , PatelDV.\n          Near fatal case of amlodipine poisoning in an infant. Indian J Pediatr. 2013;80(6)513\u2013515."},{"issue":"5","key":"i1551-6776-24-5-378-b6","series-title":"Am J Crit Care","first-page":"498","article-title":"Hyperinsulinemic euglycemia therapy for verapamil poisoning: a review","volume":"16","year":"2007","unstructured":"Patel\n              NP\n            , PughME, GoldbergS, EigerG.\n          Hyperinsulinemic euglycemia therapy for verapamil poisoning: a review. Am J Crit Care. 2007;16(5):498\u2013503."},{"issue":"4","key":"i1551-6776-24-5-378-b7","series-title":"Tex Heart Inst J","first-page":"575","article-title":"Hyperinsulinemia euglycemia therapy for calcium channel blocker overdose","volume":"39","year":"2012","unstructured":"Agarwal\n              A\n            , YuSW, RehmanA, HenkleJQ.\n          Hyperinsulinemia euglycemia therapy for calcium channel blocker overdose. Tex Heart Inst J. 2012;39(4):575\u2013578."},{"issue":"12","key":"i1551-6776-24-5-378-b8","series-title":"Pharmacotherapy","first-page":"1802","article-title":"Bezoar formation requiring endoscopic removal after intentional overdose of extended-release nifedipine","volume":"26","year":"2006","unstructured":"Wells\n              CD\n            , LuckritzTC, RadyMY, \n          et al. Bezoar formation requiring endoscopic removal after intentional overdose of extended-release nifedipine. Pharmacotherapy. 2006;26(12):1802\u20131805."},{"issue":"2","key":"i1551-6776-24-5-378-b9","series-title":"J Emerg Med","first-page":"186","article-title":"Amlodipine toxicity in children less than 6 years of age: a dose-response analysis using national poison data system data","volume":"39","year":"2010","unstructured":"Benson\n              BE\n            , SpykerDA, TroughtmanWG, \n          et al. Amlodipine toxicity in children less than 6 years of age: a dose-response analysis using national poison data system data. J Emerg Med. 2010;39(2):186\u2013193."},{"issue":"6","key":"i1551-6776-24-5-378-b10","series-title":"Ann Emerg Med","first-page":"649","article-title":"Calcium channel blocker toxicity","volume":"19","year":"1990","unstructured":"Ramoska\n              EA\n            , SpillerHA, MyersA.\n          Calcium channel blocker toxicity. Ann Emerg Med. 1990;19(6):649\u2013653."},{"issue":"2","key":"i1551-6776-24-5-378-b11","series-title":"Ann Emerg Med","first-page":"196","article-title":"A one-year evaluation of calcium channel blocker overdoses: toxicity and treatment","volume":"22","year":"1993","unstructured":"Ramoska\n              EA\n            , SpillerHA, WinterM, BorysD.\n          A one-year evaluation of calcium channel blocker overdoses: toxicity and treatment. Ann Emerg Med. 1993;22(2):196\u2013200."},{"issue":"2","key":"i1551-6776-24-5-378-b12","series-title":"J Med Toxicol","first-page":"179","article-title":"Amlodipine fatality in an infant with postmortem blood levels","volume":"8","year":"2012","unstructured":"Spiller\n              HA\n            , MillinerBA, BosseGM.\n          Amlodipine fatality in an infant with postmortem blood levels. J Med Toxicol. 2012;8(2):179\u2013182."},{"issue":"8","key":"i1551-6776-24-5-378-b13","series-title":"Pediatr Emer Care","first-page":"532","article-title":"Calcium channel blocker toxicity","volume":"25","year":"2009","unstructured":"Arroyo\n              AM\n            , KaoLW.\n          Calcium channel blocker toxicity. Pediatr Emer Care. 2009;25(8):532\u2013541."},{"issue":"7","key":"i1551-6776-24-5-378-b14","series-title":"Clin Toxicol","first-page":"797","article-title":"Calcium channel blocker ingestion: an evidence-based consensus guideline for out-of-hospital management","volume":"43","year":"2005","unstructured":"Olson\n              KR\n            , ErdmanAR, WoolfAD, \n          et al. Calcium channel blocker ingestion: an evidence-based consensus guideline for out-of-hospital management. Clin Toxicol. 2005;43(7):797\u2013822."},{"key":"i1551-6776-24-5-378-b15","series-title":"Crit Care Med","first-page":"e306","article-title":"Expert consensus recommendations for the management of calcium channel blocker poisoning in adults","volume":"45","year":"2017","unstructured":"St-Onge\n              M\n            , AnseeuwK, CantrellFL, \n          et al. Expert consensus recommendations for the management of calcium channel blocker poisoning in adults. Crit Care Med. 2017;45:e306\u2013e315."},{"issue":"2","key":"i1551-6776-24-5-378-b16","series-title":"Clin Toxicol (Phila)","first-page":"61","article-title":"Position paper: single-dose activated charcoal","volume":"43","year":"2005","unstructured":"Chyka\n              PA\n            , SegerD, KrenzelokEP, ValeJA; American Academy of Clinical Toxicology; European Association of Poisons Centres and Clinical Toxicologists. \n          Position paper: single-dose activated charcoal. Clin Toxicol (Phila). 2005;43(2):61\u201387."},{"issue":"3","key":"i1551-6776-24-5-378-b17","series-title":"Br J Clin Pharmacol","first-page":"274","article-title":"Gastric decontamination performed 5 min after the ingestion of temazepam, verapamil and moclobemide: charcoal is superior to lavage","volume":"49","year":"2000","unstructured":"Lapatto-Reiniluoto\n              O\n            , Kivist\u00f6KT, NeuvonenPJ.\n          Gastric decontamination performed 5 min after the ingestion of temazepam, verapamil and moclobemide: charcoal is superior to lavage. Br J Clin Pharmacol. 2000;49(3):274\u2013278."},{"issue":"3","key":"i1551-6776-24-5-378-b18","series-title":"Clin Toxicol","first-page":"140","article-title":"Position paper update: gastric lavage for gastrointestinal decontamination","volume":"51","year":"2013","unstructured":"Benson\n              BE\n            , HoppuK, TroutmanWG, \n          et al. Position paper update: gastric lavage for gastrointestinal decontamination. Clin Toxicol. 2013;51(3):140\u2013146."},{"issue":"3","key":"i1551-6776-24-5-378-b19","series-title":"Clin Pharmacol Ther","first-page":"255","article-title":"Activated charcoal alone and followed by whole-bowel irrigation in preventing the absorption of sustained-release drugs","volume":"70","year":"2001","unstructured":"Lapatto-Reiniluoto\n              O\n            , KivistoKT, NeuvonenPJ.\n          Activated charcoal alone and followed by whole-bowel irrigation in preventing the absorption of sustained-release drugs. Clin Pharmacol Ther. 2001;70(3):255\u2013260."},{"issue":"1","key":"i1551-6776-24-5-378-b20","series-title":"Br J Clin Pharmacol","first-page":"29","article-title":"Prevention of amlodipine absorption by activated charcoal: effect of delay in charcoal administration","volume":"43","year":"1997","unstructured":"Laine\n              K\n            , KivistoKT, LaaksoI, NeuvonenPJ.\n          Prevention of amlodipine absorption by activated charcoal: effect of delay in charcoal administration. Br J Clin Pharmacol. 1997;43(1):29\u201333."},{"issue":"suppl 3","key":"i1551-6776-24-5-378-b21","series-title":"Circulation","first-page":"S876","article-title":"Part 14: Pediatric Advanced Life Support: 2010 American Heart Association Guidelines for Cardiopulmonary Resuscitation and Emergency Cardiovascular Care","volume":"122","year":"2010","unstructured":"Kleinman\n              ME\n            , ChameidesL, SchexnayderSM, \n          et al. Part 14: Pediatric Advanced Life Support: 2010 American Heart Association Guidelines for Cardiopulmonary Resuscitation and Emergency Cardiovascular Care. Circulation. 2010;122(suppl 3):S876\u2013S908."},{"issue":"9","key":"i1551-6776-24-5-378-b22","series-title":"Clin Toxicol","first-page":"926","article-title":"Treatment of calcium channel blocker poisoning: a systematic review","volume":"52","year":"2014","unstructured":"St-Onge\n              M\n            , Dub\u00e9PA, GosselinS, \n          et al. Treatment of calcium channel blocker poisoning: a systematic review. Clin Toxicol. 2014;52(9):926\u2013944."},{"issue":"9","key":"i1551-6776-24-5-378-b23","series-title":"Crit Care Med","first-page":"2071","article-title":"Assessment of hyperglycemia after calcium channel blocker overdoses involving diltiazem or verapamil","volume":"35","year":"2007","unstructured":"Levine\n              M\n            , BoyerE, PoznerCN, \n          et al. Assessment of hyperglycemia after calcium channel blocker overdoses involving diltiazem or verapamil. Crit Care Med. 2007;35(9):2071\u20132075."},{"issue":"5","key":"i1551-6776-24-5-378-b24","series-title":"Ann Pharmacother","first-page":"923","article-title":"High-dose insulin therapy for calcium-channel blocker overdose","volume":"39","year":"2005","unstructured":"Shepherd\n              G\n            , Klein-SchwartzW.\n          High-dose insulin therapy for calcium-channel blocker overdose. Ann Pharmacother. 2005;39(5):923\u2013930."},{"issue":"11","key":"i1551-6776-24-5-378-b25","series-title":"Intensive Care Med","first-page":"2019","article-title":"Relative safety or hyperinsulinaemia\/euglycaemia therapy in the management of calcium channel blocker overdose: a prospective observation study","volume":"33","year":"2007","unstructured":"Greene\n              SL\n            , GawarammanaI, WoodDM, \n          et al. Relative safety or hyperinsulinaemia\/euglycaemia therapy in the management of calcium channel blocker overdose: a prospective observation study. Intensive Care Med. 2007;33(11):2019\u20132024."},{"issue":"4","key":"i1551-6776-24-5-378-b26","series-title":"J Toxicol Clin Toxicol","first-page":"463","article-title":"Insulin-glucose as adjunctive therapy for severe calcium channel antagonist poisoning","volume":"37","year":"1999","unstructured":"Yuan\n              TH\n            , KernsWP, TomaszewskiCA, \n          et al. Insulin-glucose as adjunctive therapy for severe calcium channel antagonist poisoning. J Toxicol Clin Toxicol. 1999;37(4):463\u2013474."},{"key":"i1551-6776-24-5-378-b27","series-title":"J Toxicol Clin Toxicol","first-page":"577","article-title":"Insulin \u201ceuglycemia\u201d therapy for accidental nifedipine overdose (abstract)","volume":"38","year":"2000","unstructured":"Morris-Kukoski\n              C\n            , BiswasA, ParaM.\n          Insulin \u201ceuglycemia\u201d therapy for accidental nifedipine overdose (abstract). J Toxicol Clin Toxicol. 2000;38:577."},{"key":"i1551-6776-24-5-378-b28","series-title":"Clin Intensive Care","first-page":"109","article-title":"Successful resuscitation of a verapamil intoxicated child with a dextrose-insulin infusion","volume":"14","year":"2003","unstructured":"Meyer\n              M\n            , StremskiE, ScanlonM.\n          Successful resuscitation of a verapamil intoxicated child with a dextrose-insulin infusion. Clin Intensive Care. 2003;14:109\u2013113."},{"issue":"9","key":"i1551-6776-24-5-378-b29","series-title":"Hum Exp Toxicol","first-page":"1392","article-title":"Tarka overdose in a young child","volume":"30","year":"2010","unstructured":"Dogan\n              M\n            , BasaranogluM, PekerE, \n          et al. Tarka overdose in a young child. Hum Exp Toxicol. 2010;30(9):1392\u20131398."},{"issue":"2","key":"i1551-6776-24-5-378-b30","series-title":"Eur J Emerg Med","first-page":"121","article-title":"Diltiazem poisoning treated with hyperinsulinemic euglycemia therapy and intravenous lipid emulsion","volume":"18","year":"2011","unstructured":"Montiel\n              V\n            , GougnardT, HantsonP.\n          Diltiazem poisoning treated with hyperinsulinemic euglycemia therapy and intravenous lipid emulsion. Eur J Emerg Med. 2011;18(2):121\u2013123."},{"key":"i1551-6776-24-5-378-b31","series-title":"Int J Pediatr","first-page":"7466","article-title":"Hyperinsulinemic euglycemia and intravenous lipid emulsion treatments for calcium channel blocker and beta blocker poisoning: a report of two cases","volume":"4","year":"2018","unstructured":"G\u00f6kay\n              SS\n            , Y\u0131lmazHL, Y\u0131ldizdaRD, \n          et al. Hyperinsulinemic euglycemia and intravenous lipid emulsion treatments for calcium channel blocker and beta blocker poisoning: a report of two cases. Int J Pediatr. 2018;4:7466\u20137472."},{"issue":"2","key":"i1551-6776-24-5-378-b32","series-title":"Curr Drug Saf","first-page":"1","article-title":"Amlodipine (150 mg) poisoning, a case study","volume":"13","year":"2018","unstructured":"Raj\n              A\n            , PandaPK, SinghSS.\n          Amlodipine (150 mg) poisoning, a case study. Curr Drug Saf. 2018;13(2):1\u20134."},{"key":"i1551-6776-24-5-378-b33","series-title":"Clin Toxicol","first-page":"742","article-title":"Hyperinsulinemic euglycemia, continuous veno venous hemofiltration, and extracorporeal life support for severe verapamil poisoning: case report (abstract 198)","volume":"47","year":"2009","unstructured":"Aaronson\n              PM\n            , WassilSK, KunisakiTA.\n          Hyperinsulinemic euglycemia, continuous veno venous hemofiltration, and extracorporeal life support for severe verapamil poisoning: case report (abstract 198). Clin Toxicol. 2009;47:742."},{"issue":"2","key":"i1551-6776-24-5-378-b34","series-title":"Cardiovasc Toxicol","first-page":"223","article-title":"Survival after cardiac arrest: ECMO rescue therapy after amlodipine and metoprolol overdose","volume":"17","year":"2017","unstructured":"Maskell\n              KF\n            , FergusonNM, BainJ, WillsBK.\n          Survival after cardiac arrest: ECMO rescue therapy after amlodipine and metoprolol overdose. Cardiovasc Toxicol. 2017;17(2):223\u2013225."},{"issue":"7","key":"i1551-6776-24-5-378-b35","series-title":"Clin Toxicol","first-page":"653","article-title":"High-dose insulin: a consecutive case series in toxin-induced cardiogenic shock","volume":"49","year":"2011","unstructured":"Holger\n              JS\n            , StellpflugSJ, ColeJB, \n          et al. High-dose insulin: a consecutive case series in toxin-induced cardiogenic shock. Clin Toxicol. 2011;49(7):653\u2013658."},{"issue":"10","key":"i1551-6776-24-5-378-b36","series-title":"J Hosp Med","first-page":"663","article-title":"Management of calcium channel blocker overdoses","volume":"9","year":"2014","unstructured":"Shenoy\n              S\n            , LankalaS, AdigopulaS.\n          Management of calcium channel blocker overdoses. J Hosp Med. 2014;9(10):663\u2013668."},{"issue":"3","key":"i1551-6776-24-5-378-b37","series-title":"Clin Toxicol","first-page":"167","article-title":"Systematic review of the effect of intravenous lipid emulsion therapy for local anesthetic toxicity","volume":"54","year":"2016","unstructured":"Hoegberg\n              LC\n            , BaniaTC, LavergneV, \n          et al. Systematic review of the effect of intravenous lipid emulsion therapy for local anesthetic toxicity. Clin Toxicol. 2016;54(3):167\u2013193."},{"issue":"1","key":"i1551-6776-24-5-378-b38","series-title":"Emerg Med Clin N Am","first-page":"79","article-title":"Toxin-induced cardiovascular failure","volume":"32","year":"2014","unstructured":"Jang\n              DH\n            , SpyresMB, FoxLF, ManiniAF.\n          Toxin-induced cardiovascular failure. Emerg Med Clin N Am. 2014;32(1):79\u2013102."},{"issue":"2","key":"i1551-6776-24-5-378-b39","series-title":"Acad Emerg Med","first-page":"134","article-title":"Intralipid prolongs survival in a rat model of verapamil toxicity","volume":"13","year":"2006","unstructured":"Tebbutt\n              S\n            , HarveyM, NicholsonT, CaveG.\n          Intralipid prolongs survival in a rat model of verapamil toxicity. Acad Emerg Med. 2006;13(2):134\u2013139."},{"issue":"2","key":"i1551-6776-24-5-378-b40","series-title":"Acad Emerg Med","first-page":"105","article-title":"Hemodynamic effects of intravenous fat emulsion in an animal model of verapamil toxicity resuscitated with atropine","volume":"14","year":"2007","unstructured":"Bania\n              TC\n            , ChuJ, PerezE, \n          et al. Hemodynamic effects of intravenous fat emulsion in an animal model of verapamil toxicity resuscitated with atropine. Acad Emerg Med. 2007;14(2):105\u2013111."},{"issue":"5","key":"i1551-6776-24-5-378-b41","series-title":"Ann Pharmacother","first-page":"735","article-title":"Intravenous lipid emulsion to reverse acute drug toxicity in pediatric patients","volume":"47","year":"2013","unstructured":"Presley\n              JD\n            , ChykaPA.\n          Intravenous lipid emulsion to reverse acute drug toxicity in pediatric patients. Ann Pharmacother. 2013;47(5):735\u2013743."},{"issue":"2","key":"i1551-6776-24-5-378-b42","series-title":"Postgrad Med","first-page":"119","article-title":"Role of intravenous lipid emulsions in the management of calcium channel blocker and \u03b2-blocker overdose: 3 years experience of a university hospital","volume":"127","year":"2015","unstructured":"Sebe\n              A\n            , DiselNR, AkpinarAA, KarakocE.\n          Role of intravenous lipid emulsions in the management of calcium channel blocker and \u03b2-blocker overdose: 3 years experience of a university hospital. Postgrad Med. 2015;127(2):119\u2013124."},{"issue":"3","key":"i1551-6776-24-5-378-b43","series-title":"Clin Toxicol","first-page":"197","article-title":"Utilization of lipid emulsion therapy in fatal overdose cases: an observational study","volume":"57","year":"2018","unstructured":"Smolinske\n              S\n            , HoffmanRS, VilleneuveE, \n          et al. Utilization of lipid emulsion therapy in fatal overdose cases: an observational study. Clin Toxicol. 2018;57(3):197\u2013202."},{"issue":"10","key":"i1551-6776-24-5-378-b44","series-title":"Clin Toxicol","first-page":"899","article-title":"Evidence-based recommendations on the use of intravenous lipid emulsion therapy in poisoning","volume":"54","year":"2016","unstructured":"Gosselin\n              S\n            , HoegbergLC, HoffmanRS, \n          et al. Evidence-based recommendations on the use of intravenous lipid emulsion therapy in poisoning. Clin Toxicol. 2016;54(10):899\u2013923."},{"issue":"2","key":"i1551-6776-24-5-378-b45","series-title":"Reg Anesth Pain Med","first-page":"150","article-title":"The American Society of Regional Anesthesia and Pain Medicine Checklist for Managing Local Anesthetic Systemic Toxicity: 2017 Version","volume":"43","year":"2018","unstructured":"Neal\n              JM\n            , WoodwardCM, HarrisonTK.\n          The American Society of Regional Anesthesia and Pain Medicine Checklist for Managing Local Anesthetic Systemic Toxicity: 2017 Version. Reg Anesth Pain Med. 2018;43(2):150\u2013153."},{"issue":"1","key":"i1551-6776-24-5-378-b46","series-title":"J Med Toxicol","first-page":"81","article-title":"ACMT position statement: interim guidance for the use of lipid resuscitation therapy","volume":"7","year":"2011","unstructured":"American College of Medical Toxicology. \n          ACMT position statement: interim guidance for the use of lipid resuscitation therapy. J Med Toxicol. 2011;7(1):81\u201382."},{"key":"i1551-6776-24-5-378-b47","series-title":"Intralipid 20% (20% I.V. fat emulsion) [package insert]","year":"2015","unstructured":"Intralipid 20% (20% I.V. fat emulsion) [package insert]. Uppsala, Sweden: Fresenius Kabi; 2015."},{"key":"i1551-6776-24-5-378-b48","series-title":"Crit Care","first-page":"R138","article-title":"Extracorporeal life support in severe drug intoxication: a retrospective cohort study of seventeen cases","volume":"13","year":"2009","unstructured":"Daubin\n              C\n            , LehouxP, IvascauC, \n          et al. Extracorporeal life support in severe drug intoxication: a retrospective cohort study of seventeen cases. Crit Care. 2009;13:R138."},{"key":"i1551-6776-24-5-378-b49","series-title":"Case Rep Crit Care","article-title":"Circulatory support with venoarterial ECMO unsuccessful in aiding endogenous diltiazem clearance after overdose","volume":"2014","year":"2014","unstructured":"Frazee\n              EN\n            , LeeSJ, KalimullahEA, \n          et al. Circulatory support with venoarterial ECMO unsuccessful in aiding endogenous diltiazem clearance after overdose. Case Rep Crit Care. 2014;2014:969578."},{"issue":"3","key":"i1551-6776-24-5-378-b50","series-title":"Pediatr Crit Care Med","first-page":"372","article-title":"Massive diltiazem overdose treated with extracorporeal membrane oxygenation","volume":"4","year":"2003","unstructured":"Durward\n              A\n            , GuerguerianAM, LefebvreM, ShemieSD.\n          Massive diltiazem overdose treated with extracorporeal membrane oxygenation. Pediatr Crit Care Med. 2003:4(3):372\u2013376."},{"key":"i1551-6776-24-5-378-b51","series-title":"BMJ Case Rep","article-title":"Methylene blue reverses recalcitrant shock in beta-blocker and calcium channel blocker overdose","year":"2013","unstructured":"Aggarwal\n              N\n            , KupferY, SenevirantneC, TesslerS.\n          Methylene blue reverses recalcitrant shock in beta-blocker and calcium channel blocker overdose. BMJ Case Rep. 2013. doi: 10.1136\/bcr-2012-007402"}],"container-title":["The Journal of Pediatric Pharmacology and Therapeutics"],"original-title":[],"link":[{"URL":"https:\/\/jppt.kglmeridian.com\/view\/journals\/jppt\/24\/5\/article-p378.xml","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/meridian.allenpress.com\/jppt\/article-pdf\/24\/5\/378\/2466010\/1551-6776-24_5_378.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/jppt.kglmeridian.com\/downloadpdf\/journals\/jppt\/24\/5\/article-p378.xml","content-type":"text\/html","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/jppt.kglmeridian.com\/downloadpdf\/journals\/jppt\/24\/5\/article-p378.xml","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,5,16]],"date-time":"2025-05-16T00:40:37Z","timestamp":1747356037000},"score":1,"resource":{"primary":{"URL":"https:\/\/jppt.kglmeridian.com\/view\/journals\/jppt\/24\/5\/article-p378.xml"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019]]},"references-count":51,"journal-issue":{"issue":"5"},"URL":"https:\/\/doi.org\/10.5863\/1551-6776-24.5.378","relation":{},"ISSN":["1551-6776"],"issn-type":[{"value":"1551-6776","type":"print"}],"subject":[],"published":{"date-parts":[[2019]]}}}